| Particulars (Rupees in Crores.) | Sept-2024 | Mar-2024 | Sept-2023 | Mar-2023 | Sept-2022 |
|---|---|---|---|---|---|
Gross Sales | 1,548 | 1,401 | 1,397 | 1,377 | 1,274 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 1,548 | 1,401 | 1,397 | 1,377 | 1,274 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 39 | 45 | 38 | 8 | 114 |
Total Income | 1,587 | 1,446 | 1,435 | 1,385 | 1,388 |
Total Expenditure | 1,347 | 1,450 | 1,323 | 1,402 | 1,442 |
PBIDT | 240 | -4 | 112 | -17 | -54 |
Interest | 146 | 150 | 155 | 159 | 143 |
PBDT | 94 | -154 | -43 | -176 | -197 |
Depreciation | 109 | 113 | 110 | 122 | 129 |
Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 |
Tax | 5 | 5 | 11 | 4 | 8 |
Deferred Tax | 12 | -9 | 45 | 37 | -52 |
Reported Profit After Tax | -32 | -263 | -209 | -339 | -282 |
Minority Interest After NP | 4 | -11 | 2 | -36 | -26 |
Net Profit after Minority Interest | -36 | -252 | -211 | -303 | -256 |
Extra-ordinary Items | 0 | -52 | -8.88 | -99 | -190.21 |
Adjusted Profit After Extra-ordinary item | -36 | -200 | -202.12 | -204 | -65.79 |
EPS (Unit Curr.) | -2.42 | 0 | -14.65 | 0 | -17.8 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 |
Dividend (%) | 0 | 0 | 0 | 0 | 0 |
Equity | 77 | 77 | 72 | 72 | 72 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
PBIDTM(%) | 15.5 | -0.28 | 8.01 | -1.23 | -4.23 |
PBDTM(%) | - | - | - | - | - |
PATM(%) | -2.06 | -18.77 | -14.96 | -24.61 | -22.13 |
WCK 6777 is the only once-a-day antibiotic in the global pipeline designated for outpatient parenteral antimicrobial therapy (OPAT).
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
